Author  
Place of duty  
Title   전신기 소세포 폐암에 대한 EP 화학요법과 EP / CAV 교대화학요법의 비교 연구 ( A Randomized Comparison of EP Sequential Chemotherapy Versus EP / CAV Alternating Chemotherapy for Extencive - stage Small - cell Lung Cancer )
Publicationinfo   1994 Jan; 026(05): 786-793.
Key_word   Small cell lung cancer, combination chemotherapy
Full-Text  
Abstract   The present randomized, prospective study was designed to assess whether alternating etoposide, cisplatin (EP) and cyclophosphamide, adriamycin, vincristine (CAV) is better than etoposide, cisplatin (EP) chemotherapy in improving response, survival and remission duration in 62 evaluable patients having extensive-stage small-cell lung cancer.(SCLC) There were no significant differences in treatment outcome for EP alone, EP/CAV in terms of response rate (65/ versus 75%), complete response rate (9% versus 7%), remission duration (5 months versus 5 months) or median survival (10 months versus 1 l months). Severe myelosuppressian was more common in EPiCAV alternating treatment. The EP/CAV alternating regimen and EP alone regimen can be considered equivalently effective induction therapies in extensive SCLC and these two regimens are, to some degree, cross resistant. Alternating therapy provides no therapeutic advantage with more myelosuppression compared to the EP alone chemotherapy and should not be considered as standard treatment in this clinical setting.
저 자   허대석(Dae Seog Heo),방영주(Yung Jue Bang),김노경(Noe Kyeong Kim),박영석(Young Suk Park),서창인(Chang In Suh),정기석(Ki Suck Chang)